Page last updated: 2024-10-25

ci 994 and Medulloblastoma

ci 994 has been researched along with Medulloblastoma in 1 studies

tacedinaline: oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells
tacedinaline : A benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers.

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Marquardt, V1
Theruvath, J1
Pauck, D1
Picard, D1
Qin, N1
Blümel, L1
Maue, M1
Bartl, J1
Ahmadov, U1
Langini, M1
Meyer, FD1
Cole, A1
Cruz-Cruz, J1
Graef, CM1
Wölfl, M1
Milde, T1
Witt, O1
Erdreich-Epstein, A1
Leprivier, G1
Kahlert, U1
Stefanski, A1
Stühler, K1
Keir, ST1
Bigner, DD1
Hauer, J1
Beez, T1
Knobbe-Thomsen, CB1
Fischer, U1
Felsberg, J1
Hansen, FK1
Vibhakar, R1
Venkatraman, S1
Cheshier, SH1
Reifenberger, G1
Borkhardt, A1
Kurz, T1
Remke, M1
Mitra, S1

Other Studies

1 other study available for ci 994 and Medulloblastoma

ArticleYear
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammat
    Journal for immunotherapy of cancer, 2023, Volume: 11, Issue:1

    Topics: Animals; Cerebellar Neoplasms; Glioblastoma; Histone Deacetylase Inhibitors; Humans; Inflammation; M

2023